A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.
A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease.
Active, not recruiting · NCT07339514 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Study of ER2001 Injection for the Treatment of Early Manifest Huntington's Disease. | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-01-14 | NCT07339514 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ExoRNA Bioscience | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 1 |
| First Affiliated Hospital of Sun Yat-sen University | Guangzhou | China | 2 |
| West China Hospital of Sichuan University | Chengdu | China | 117 |